| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/22/2001 | CA2382090A1 Coxsackie virus-derived vector system for gene transfer |
| 02/22/2001 | CA2382048A1 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 02/22/2001 | CA2382019A1 Isomerase proteins |
| 02/22/2001 | CA2382018A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2382015A1 Membrane associated proteins |
| 02/22/2001 | CA2381979A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | CA2381927A1 Herbicide-tolerant protoporphyrinogen oxidase |
| 02/22/2001 | CA2381863A1 Novel transcription factor, bp1 |
| 02/22/2001 | CA2381798A1 Method for treatment of .beta.-hemoglobinopathies |
| 02/22/2001 | CA2381794A1 Helical cytokine zalpha48 |
| 02/22/2001 | CA2381712A1 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 02/22/2001 | CA2381706A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 02/22/2001 | CA2381163A1 Transgenically modified plant cells and plants having modified gbssi- and be-protein activity |
| 02/22/2001 | CA2380888A1 Treatment of metastatic disease |
| 02/22/2001 | CA2380753A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 02/22/2001 | CA2380635A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor |
| 02/22/2001 | CA2378173A1 Nucleic acid molecules derived from plants which code for enzymes which are involved in the synthesis of starch |
| 02/22/2001 | CA2377662A1 Novel protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 02/22/2001 | CA2372991A1 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and related fatty acids having a modification at the delta-9 position |
| 02/21/2001 | EP1077254A2 Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof |
| 02/21/2001 | EP1077253A1 Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair |
| 02/21/2001 | EP1077072A2 In vitro process for the preparation of heart valve or vessel prothese |
| 02/21/2001 | EP1077068A1 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 02/21/2001 | EP1076714A1 Construction of retroviral producer cells from adenoviral and retroviral vectors |
| 02/21/2001 | EP1076713A1 Human bmp-7 promoter and method for exploring bone-related substance by using the same |
| 02/21/2001 | EP1076711A2 Human apoptosis associated proteins |
| 02/21/2001 | EP1076710A2 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 02/21/2001 | EP1076708A2 Method for the production of 1,3-propanediol by recombinant organisms comprising genes for vitamin b 12 transport |
| 02/21/2001 | EP1076706A2 Methods and compositions for expression of transgenes in plants |
| 02/21/2001 | EP1076705A2 Transcription and gene expression regulators |
| 02/21/2001 | EP1076703A2 Il-17 homologous polypeptides and therapeutic uses thereof |
| 02/21/2001 | EP1076702A1 Human protease associated proteins |
| 02/21/2001 | EP1076700A2 Human nucleic acid sequences obtained from pancreas tumor tissue |
| 02/21/2001 | EP1076691A1 Cellular and animal models for diseases associated with altered mitochondrial function |
| 02/21/2001 | EP1076690A2 Methods for modulating differentiation |
| 02/21/2001 | EP1076689A1 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same |
| 02/21/2001 | EP1076664A2 Human bmp-4 promoter and method for exploring bone-related substance by using the same |
| 02/21/2001 | EP1076662A2 Polyepitope carrier protein |
| 02/21/2001 | EP1076569A1 Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto |
| 02/21/2001 | EP0871470A4 Haemopoietic growth factor antagonists and uses therefor |
| 02/21/2001 | EP0784683B1 Tie-2 ligands, methods of making and uses thereof |
| 02/21/2001 | EP0652968B1 Defective adenoviruses |
| 02/21/2001 | EP0580635B2 Modified plant viruses as vectors |
| 02/21/2001 | EP0526452B1 Hybrid immunoglobulins |
| 02/21/2001 | CN1285000A Equine infections anaemia virus (EIAV) based |
| 02/21/2001 | CN1284999A Maize H3C4 promoter associated with first rice actin intron, chimeric gene containing it and transformed plant |
| 02/21/2001 | CN1284997A Modified deacetoxycephalosporin C synthase (DAOCS) and x-ray structure |
| 02/21/2001 | CN1284995A Tissue cement proteins from rhipicephalus appendiculatus |
| 02/21/2001 | CN1284993A Pluripotent embryonic stem cells and methods of obtaining them |
| 02/21/2001 | CN1284966A Novel G protein-coupled receptor |
| 02/21/2001 | CN1284962A Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof |
| 02/21/2001 | CN1284886A Methods for quenching pathogen inactivators in biological materials |
| 02/21/2001 | CN1284882A Beta-lipotropin and uses thereof |
| 02/21/2001 | CN1062308C Hair fillicle culture in vitro method |
| 02/20/2001 | US6191267 Cloning and producing the N.BstNBI nicking endonuclease |
| 02/20/2001 | US6191258 Polypeptide which associates with symetric nucleotide sequences; for the artificial regulation of gene expression in plants |
| 02/20/2001 | US6191154 Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases |
| 02/20/2001 | US6191104 Methods of treating graft rejection with the IL-17 receptor |
| 02/20/2001 | US6190913 Propagating preferential aggregates; providing sterlized plastic bag, fill bag with gas containg oxygen, inserting liquid nutrients and aggregate into bag, join bag to platform, rock the platform and allow propagation |
| 02/20/2001 | US6190910 Eukaryotic progenitor cells for utilization as tools in genetic engineering the treatment of human defects |
| 02/20/2001 | US6190909 TH2-specific gene |
| 02/20/2001 | US6190905 Cleaning contact lens; incubating contact lens with proteolytic enzyme, wash several times in buffer, store for utilization |
| 02/20/2001 | US6190893 Contacting stromal cells with substrate having electroactive surface, surface is attached to/or associated with mammalian cell tissue; and applying electromagnetic stimulation; tissue engineering of bone regeneration and repair |
| 02/20/2001 | US6190887 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein |
| 02/20/2001 | US6190886 Trimerizing polypeptides, their manufacture and use |
| 02/20/2001 | US6190881 Polynucleotide; recombinant production; drug screening of bactericides and enzyme inhibitors |
| 02/20/2001 | US6190880 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 02/20/2001 | US6190876 KUZ, a novel family of metalloproteases |
| 02/20/2001 | US6190875 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 02/20/2001 | US6190874 Methods for identifying compounds that bind to CSAPK-1 |
| 02/20/2001 | US6190871 Determining efficacy of monoclonal antibody to neutralize primary isolates by culturing various concentrations of antibody with virus and h9 cells, determining concentration of p24 antigen as indicator of infection, and comparing |
| 02/20/2001 | US6190860 Method to detect CMV by hybridization with a gp55 specific DNA probe |
| 02/20/2001 | US6190855 Systems and methods for removing viral agents from blood |
| 02/20/2001 | US6190666 Can be used to transform animal cells for use in efficient production of desired products, such as proteins and vaccines |
| 02/20/2001 | US6190655 Methods of using Flt-3 ligand for exogenous gene transfer |
| 02/20/2001 | CA2206399C Method for secreting thrombopoietin polypeptides |
| 02/20/2001 | CA2199403C Novel pka-binding proteins and uses thereof |
| 02/20/2001 | CA2139846C Modular promoter construct |
| 02/20/2001 | CA2119651C Immunoassay for identifying alcoholics and monitoring alcohol consumption |
| 02/20/2001 | CA1341182C Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 02/19/2001 | CA2316413A1 Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair |
| 02/19/2001 | CA2316400A1 Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof |
| 02/15/2001 | WO2001011071A2 Bioproduction of para-hydroxycinnamic acid |
| 02/15/2001 | WO2001011067A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 02/15/2001 | WO2001011064A2 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 02/15/2001 | WO2001011052A2 Monocellular or multicellular organisms for the production of riboflavin |
| 02/15/2001 | WO2001011051A2 Chimeric proteins |
| 02/15/2001 | WO2001011050A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 02/15/2001 | WO2001011047A2 Dna sequences isolated from human colonic epithelial cells |
| 02/15/2001 | WO2001011046A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | WO2001011041A1 MONOMERIC PROTEIN OF THE TGF-β FAMILY |
| 02/15/2001 | WO2001011035A1 Monoclonal antibodies for human cytochrome p450 3a4 and human cytochrome p450 2c9 |
| 02/15/2001 | WO2001011034A2 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
| 02/15/2001 | WO2001011031A2 Gene transfer to pancreatic beta cells for prevention of islet dysfunction |
| 02/15/2001 | WO2001011030A2 Method and means for inducing cell-multiplication of non-active cells |
| 02/15/2001 | WO2001011028A1 Glucuronoxylomannan (gxm)-o-acetylhydrolase of cryptococcus neoformans and uses thereof |
| 02/15/2001 | WO2001011027A1 New protein |
| 02/15/2001 | WO2001011021A1 Recombinant stabile cell clone, its production and use thereof |
| 02/15/2001 | WO2001011020A1 Method of making plant artificial chromosomes |
| 02/15/2001 | WO2001011019A1 Method of producing an undifferentiated avian cell culture using avian primordial germ cells |